Volume 58, Issue 1, Pages (July 2000)

Slides:

Advertisements

Similar presentations

Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study Mark Unruh, Robert Benz, Tom Greene, Guofen Yan, Srinivasan.

Advertisements

Acid-base profile in patients on PD

A.M. Thompson, T.G. Pickering Kidney International

Volume 56, Pages S238-S241 (July 1999)

LDL cholesterol in CKD—to treat or not to treat?

Volume 54, Issue 2, Pages (August 1998)

Linear and logistic regression analysis

Acid-base profile in patients on PD

Volume 58, Issue 4, Pages (October 2000)

Determinants of phosphorus mobilization during hemodialysis

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

The risk of hospitalization and modality failure with home dialysis

Volume 80, Issue 1, Pages (July 2011)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 64, Issue 3, Pages (September 2003)

Volume 60, Issue 4, Pages (October 2001)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease Jessica Kendrick,

Volume 86, Issue 4, Pages (October 2014)

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie

Volume 81, Issue 3, Pages (February 2012)

Volume 79, Issue 12, Pages (June 2011)

Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.

Homocysteine and risk in end-stage renal disease: a matter of context

Volume 63, Issue 3, Pages (March 2003)

Volume 68, Issue 4, Pages (October 2005)

Volume 76, Issue 10, Pages (November 2009)

Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients Tatsuya Shoji, Yoshiharu Tsubakihara,

Volume 77, Issue 7, Pages (April 2010)

Volume 82, Issue 5, Pages (September 2012)

Stephen P. McDonald Kidney International Supplements

Volume 66, Issue 1, Pages (July 2004)

Study of Heart and Renal Protection (SHARP)

Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli

LDL cholesterol in CKD—to treat or not to treat?

Volume 74, Issue 9, Pages (November 2008)

Volume 54, Issue 2, Pages (August 1998)

Volume 76, Issue 6, Pages (September 2009)

Volume 86, Issue 3, Pages (September 2014)

Blood pressure targets in hemodialysis patients

Volume 73, Issue 12, Pages (June 2008)

Volume 62, Issue 5, Pages (November 2002)

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Volume 87, Issue 1, Pages (January 2015)

Volume 61, Issue 1, Pages (January 2002)

Volume 64, Issue 3, Pages (September 2003)

Volume 79, Issue 2, Pages (January 2011)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 82, Issue 3, Pages (August 2012)

Volume 68, Issue 1, Pages (July 2005)

Cardio-Kidney-Damage: a unifying concept

Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1 Robert N. Foley, Charles A. Herzog, Allan J.

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 77, Issue 7, Pages (April 2010)

Volume 61, Issue 2, Pages (February 2002)

Volume 66, Issue 1, Pages (July 2004)

Volume 72, Issue 2, Pages (July 2007)

Volume 60, Issue 3, Pages (September 2001)

Volume 56, Pages S238-S241 (July 1999)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Volume 68, Issue 1, Pages (July 2005)

Volume 75, Issue 1, Pages (January 2009)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Importance of blood pressure control in hemodialysis patient survival

Volume 68, Issue 1, Pages (July 2005)

Fetuin-A is not associated with mortality in chronic kidney disease

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 58, Issue 1, Pages 353-362 (July 2000) Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Alfred K. Cheung, Mark J. Sarnak, Guofen Yan, Johanna T. Dwyer, Robert J. Heyka, Michael V. Rocco, Brendan P. Teehan, Andrew S. Levey Kidney International Volume 58, Issue 1, Pages 353-362 (July 2000) DOI: 10.1046/j.1523-1755.2000.00173.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of serum total cholesterol levels (A) and predialysis systolic (B) and predialysis diastolic (C) blood pressure values in the HEMO Study cohort. Kidney International 2000 58, 353-362DOI: (10.1046/j.1523-1755.2000.00173.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between age and probability of having coronary heart disease (A), cerebrovascular disease (B), and peripheral vascular disease (C). The probabilities are adjusted for all other covariates described in the Methods section, including duration of dialysis and different dialysis centers. The broken lines represent 95% confidence intervals. There is a significant positive association between each of these disease categories and age. The association of age with the risk of coronary heart disease (expressed as the natural logarithm of the odds) was significantly nonlinear (P = 0.021), with a stronger relationship observed at lower ages. Kidney International 2000 58, 353-362DOI: (10.1046/j.1523-1755.2000.00173.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between serum total cholesterol concentration and probability of having coronary heart disease (A), cerebrovascular disease (B), and peripheral vascular disease (C). The probabilities are adjusted for all other covariates described in the Methods section, including duration of dialysis and different dialysis centers. The broken lines represent 95% confidence intervals. There is no statistically significant linear or nonlinear relationship between serum cholesterol concentration and the natural logarithm of the odds of developing any of the three types of atherosclerotic diseases. Kidney International 2000 58, 353-362DOI: (10.1046/j.1523-1755.2000.00173.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between predialysis systolic blood pressure and probability of having coronary heart disease (A), cerebrovascular disease (B), and peripheral vascular disease (C). The probabilities are adjusted for all other covariates described in the Methods section, including duration of dialysis and different dialysis centers. The broken lines represent 95% confidence intervals. There is no statistically significant linear or nonlinear relationship between predialysis systolic blood pressure and the natural logarithm of the odds of developing any of the three types of atherosclerotic diseases. Kidney International 2000 58, 353-362DOI: (10.1046/j.1523-1755.2000.00173.x) Copyright © 2000 International Society of Nephrology Terms and Conditions